The Journal of Immunology, Vol 138, Issue 12 4128-4132, Copyright © 1987 by American Association of Immunologists

ARTICLES

Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells

D Kozbor, A Moretta, HA Messner, L Moretta and CM Croce

We have analyzed cells of the B lineage for expression of the Tp44 antigen, a 44,000 homodimer detected by monoclonal antibody 9.3 on approximately 80% of mature human T lymphocytes. Previous evidence has suggested that Tp44 may function as a receptor for accessory signals in T cell activation. High level Tp44 expression was observed on plasmacytomas grown in cell culture and on plasma cells from bone marrow biopsies of multiple myeloma patients. This antigen is not present on resting B cells from either peripheral blood or lymphoid organs, or on any other B cell tumor. The growth kinetics and Ig production in plasmacytomas are not affected by the binding of antibody 9.3. Moreover, the Tp44 molecule is co-expressed with PCA-1, an antigen characteristic of plasma cells, on peripheral blood B cells stimulated in vitro to differentiate toward plasma cells. Tp44 may represent a later stage of B cell differentiation than PCA-1 because unlike the PCA- 1 antigen, this molecule could not be detected on any EBV-transformed cell line or Burkitt's lymphoma lines. The m.w. of the Tp44 molecule expressed on plasma cells and on T cells is identical, as determined by immunoprecipitation of radioiodinated cell surface proteins with monoclonal antibody 9.3. This antigen might be useful in studying the mechanism of growth and differentiation of human B cells, the heterogeneity within plasma cell populations, and B cell interactions with other components of the immune system.

This article has been cited by other articles:

				D. Quandt, H. Hoff, M. Rudolph, S. Fillatreau, and M. C. Brunner-Weinzierl A New Role of CTLA-4 on B Cells in Thymus-Dependent Immune Responses In Vivo J. Immunol., December 1, 2007; 179(11): 7316 - 7324. [Abstract] [Full Text] [PDF]

				N. J. Bahlis, A. M. King, D. Kolonias, L. M. Carlson, H. Y. Liu, M. A. Hussein, H. R. Terebelo, G. E. Byrne Jr, B. L. Levine, L. H. Boise, et al. CD28-mediated regulation of multiple myeloma cell proliferation and survival Blood, June 1, 2007; 109(11): 5002 - 5010. [Abstract] [Full Text] [PDF]

				V. S. Shapiro, M. N. Mollenauer, and A. Weiss Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression Blood, July 1, 2001; 98(1): 187 - 193. [Abstract] [Full Text] [PDF]

				N. Chirmule, J. Tazelaar, and J. M. Wilson Th2-Dependent B Cell Responses in the Absence of CD40-CD40 Ligand Interactions J. Immunol., January 1, 2000; 164(1): 248 - 255. [Abstract] [Full Text] [PDF]

				P. Jeannin, Y. Delneste, S. Lecoanet-Henchoz, J.-F. Gauchat, J. Ellis, and J.-Y. Bonnefoy CD86 (B7-2) on Human B Cells. A FUNCTIONAL ROLE IN PROLIFERATION AND SELECTIVE DIFFERENTIATION INTO IgE- AND IgG4-PRODUCING CELLS J. Biol. Chem., June 20, 1997; 272(25): 15613 - 15619. [Abstract] [Full Text] [PDF]

				E. A. Clark Regulation of B Lymphocytes by Dendritic Cells J. Exp. Med., March 3, 1997; 185(5): 801 - 804. [Full Text] [PDF]